UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 8.

Pascolo, S. Steering the immumnostimulation profile triggered by single stranded RNA through Toll Like Receptors. 2012, University of Zurich, Faculty of Medicine.

Rettig, L; Seidenberg, S; Parvanova, I; Samaras, P; Knuth, A; Pascolo, S (2011). Gemcitabine depletes regulatory T-cells in human and mice and enhances triggering of vaccine-specific cytotoxic T-cells. International Journal of Cancer, 129(4):832-.838.

Parvanova, I; Rettig, L; Knuth, A; Pascolo, S (2011). The form of NY-ESO-1 antigen has an impact on the clinical efficacy of anti-tumor vaccination. Vaccine, 29(22):3832-3836.

Rettig, L; Haen, S P; Bittermann, A G; von Boehmer, L; Curioni, A; Krämer, S D; Knuth, A; Pascolo, S (2010). Particle size and activation threshold: a new dimension of danger signaling. Blood, 115(22):4533-4541.

Knights, A J; Nuber, N; Thomson, C W; de la Rosa, O; Jäger, E; Tiercy, J M; van den Broek, Maries; Pascolo, S; Knuth, A; Zippelius, A (2009). Modified tumour antigen-encoding mRNA facilitates the analysis of naturally occurring and vaccine-induced CD4 and CD8 T cells in cancer patients. Cancer Immunology, Immunotherapy, 58(3):325-338.

Carralot, J P; Lemmel, C; Stevanovic, S; Pascolo, S (2008). Mass spectrometric identification of an HLA-A*0201 epitope from Plasmodium falciparum MSP-1. International Immunology, 20(11):1451-1456.

Weide, B; Carralot, J P; Reese, A; Scheel, B; Eigentler, T K; Hoerr, I; Rammensee, H G; Garbe, C; Pascolo, S (2008). Results of the first phase I/II clinical vaccination trial with direct injection of mRNA. Journal of Immunotherapy, 31(2):180-188.

Weide, B; Garbe, C; Rammensee, H G; Pascolo, S (2008). Plasmid DNA- and messenger RNA-based anti-cancer vaccination. Immunology Letters, 115(1):33-42.

This list was generated on Fri Jul 28 03:56:17 2017 CEST.